Inactive Instrument

Stereotaxis Inc Stock price OTC Bulletin Board

Equities

Advanced Medical Equipment & Technology

End-of-day quote OTC Bulletin Board
- USD 0.00% Intraday chart for Stereotaxis Inc
Sales 2024 * 30.6M Sales 2025 * 43.54M Capitalization 188M
Net income 2024 * -19M Net income 2025 * -14M EV / Sales 2024 * 6.16 x
Net cash position 2024 * - Net cash position 2025 * - EV / Sales 2025 * 4.33 x
P/E ratio 2024 *
-11.4 x
P/E ratio 2025 *
-15 x
Employees -
Yield 2024 *
-
Yield 2025 *
-
Free-Float 84.92%
More Fundamentals * Assessed data
Managers TitleAgeSince
Chief Executive Officer 57 16-09-28
Director of Finance/CFO 55 02-12-31
General Counsel - 20-12-31
Members of the board TitleAgeSince
Director/Board Member 78 05-04-30
Chief Executive Officer 57 16-09-28
Director/Board Member 68 17-02-02
More insiders
Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments and information systems for the interventional laboratory. Its proprietary robotic technology, Robotic Magnetic Navigation, fundamentally transforms endovascular interventions using precise computer-controlled magnetic fields to directly control the tip of flexible interventional catheters or devices. The Company’s primary products include the Genesis RMN System, the Odyssey Solution, and other related devices. Through its strategic relationships with fluoroscopy system manufacturers, providers of catheters and electrophysiology mapping systems, and other parties, the Company offers its customers x-ray systems and other accessory devices. The Genesis RMN System is designed to enable physicians to complete more complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites.
More about the company
  1. Stock
  2. Equities
  3. Stock Stereotaxis, Inc.
  4. Stock Stereotaxis Inc - OTC Bulletin Board